Blue Bird (BLBD) delivered earnings and revenue surprises of -1.28% and 4.54%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
bluebird bio ( NASDAQ:BLUE ) Third Quarter 2024 Results Key Financial Results Revenue: US$10.6m (down 14% from 3Q... On Thursday, Bluebird Bio Inc. (NASDAQ:BLUE) reported a third-quarter EPS loss ...